147 related articles for article (PubMed ID: 2978997)
1. Efficacy of the calcium antagonist isradipine in angina pectoris.
Parker JO; Enjalbert M; Bernstein V
Cardiovasc Drugs Ther; 1988 Mar; 1(6):661-4. PubMed ID: 2978997
[TBL] [Abstract][Full Text] [Related]
2. Duration of effects of isradipine during twice daily therapy in angina pectoris.
Thadani U; Chrysant S; Gorwit J; Giles T; Archer S; Iteld B; Singh S; Copen D; Wakeford C; Hobbs S
Cardiovasc Drugs Ther; 1994 Apr; 8(2):199-210. PubMed ID: 7918132
[TBL] [Abstract][Full Text] [Related]
3. Isradipine therapy in chronic stable angina pectoris--comparison with nifedipine.
Currie P; Saltissi S
Eur Heart J; 1991 Jul; 12(7):807-12. PubMed ID: 1832382
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of isradipine, alone and in combination, in the treatment of angina pectoris.
Rüegg PC; Nelson DJ
Am J Med; 1989 Apr; 86(4A):70-4. PubMed ID: 2565689
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
6. Comparison of isradipine and nifedipine in chronic stable angina.
Handler CE; Rosenthal E; Tsagadopoulos D; Najm Y
Int J Cardiol; 1988 Jan; 18(1):15-26. PubMed ID: 2963793
[TBL] [Abstract][Full Text] [Related]
7. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
8. Effects of the calcium antagonist, isradipine, and nifedipine on resting and exercise haemodynamics and the neurohumoral system in patients with stable chronic angina.
Mitrovic V; Rieckmann C; Kornecki P; Burger KJ; Welzel D; Schlepper M
Eur Heart J; 1990 May; 11(5):454-61. PubMed ID: 2141313
[TBL] [Abstract][Full Text] [Related]
9. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
Chen YH; Liu RC; Wang SP
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
[TBL] [Abstract][Full Text] [Related]
10. Cardiac function improvement 24 hours after isradipine SRO in patients with chronic stable angina: a double-blind randomized study.
Doat M; Hacot JP; Pavin D; Righetti A
Acta Cardiol; 1996; 51(2):155-64. PubMed ID: 8742912
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral isradipine on left ventricular function at rest and during exercise in patients with stable chronic angina: a double-blind, placebo-controlled crossover study.
Delonca J; Kipfer P; Righetti A
J Cardiovasc Pharmacol; 1992 Jan; 19(1):126-33. PubMed ID: 1375679
[TBL] [Abstract][Full Text] [Related]
12. [The treatment of chronic stable angina with isradipine. A cooperative Latin American study].
Román O; Alcocer L; Espinoza J; Arcos R; Gómez G; Mayorga E; Buzzi A; Tavella N; Romero C; Kuster F
Rev Esp Cardiol; 1991 Apr; 44(4):233-40. PubMed ID: 1829846
[TBL] [Abstract][Full Text] [Related]
13. Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent.
Kinnard DR; Harris M; Hossack KF
J Am Coll Cardiol; 1988 Sep; 12(3):791-6. PubMed ID: 2969930
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the effects of diltiazem and isradipine in patients with chronic stable angina pectoris].
Meluzín J; Lupínek Z; Novák M; Rotrekl P
Vnitr Lek; 1989 Nov; 35(11):1062-71. PubMed ID: 2533763
[TBL] [Abstract][Full Text] [Related]
15. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a new calcium antagonist PN 200-110 (isradipine) in angina pectoris.
Taylor SH; Jackson NC; Allen J; Pool PE
Am J Cardiol; 1987 Jan; 59(3):123B-129B. PubMed ID: 2949583
[TBL] [Abstract][Full Text] [Related]
17. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
18. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
[TBL] [Abstract][Full Text] [Related]
19. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.
Lam J; Chaitman BR; Crean P; Blum R; Waters DD
J Am Coll Cardiol; 1985 Aug; 6(2):447-52. PubMed ID: 3894474
[TBL] [Abstract][Full Text] [Related]
20. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
